Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shair Ahmed

Thoracic Surgery (Cardiothoracic Vascular Surgery) Phoenix, AZ Medical Doctor

NPI 1629270749 CMS profile 723206

500 W Thomas Rd Ste 500, Phoenix, AZ 85013

Open in the dashboard

General payments

$15,167

89 records reported · program years 2019–2025

Research payments

$1,116

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shair Ahmed of Phoenix, AZ is reported in the CMS Open Payments database as having received $15,167 across 89 general payments and $1,116 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,147 8
2024 General $443 9
2023 General $8,826 47
2022 General $1,048 10
2021 General $57 1
2020 General $142 4
2019 General $3,504 10
2019 Research $1,116 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shair Ahmed
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Shair Ahmed were reported at $1,147. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Shair Ahmed Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $3,504 $886 $178–$3,167 $163
2020 $142 $341 $108–$1,605 $114
2021 $57 $453 $125–$1,886 $132
2022 $1,048 $695 $180–$2,566 $149
2023 $8,826 $745 $205–$2,662 $160
2024 $443 $799 $214–$2,967 $164
2025 $1,147 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $12,507 41 payments
  2. Medtronic, Inc. $1,269 17 payments
  3. Paragonix Technologies, Inc. $324 2 payments
  4. Merit Medical Systems Inc $190 1 payment
  5. Davol Inc. $169 5 payments
  6. CryoLife, Inc. $168 2 payments
  7. KLS-Martin L.P. $157 6 payments
  8. Ethicon US, LLC $126 6 payments
  9. Atricure, Inc. $107 3 payments
  10. Eurofins Viracor, Inc. $34 1 payment
  11. Other $117 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $8,000 4 payments
  2. Travel and Lodging $4,011 26 payments
  3. Food and Beverage $3,155 59 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $8,507 39 payments
  2. ION $3,000 1 payment
  3. DAVINCI XI $1,000 1 payment
  4. Signia $844 13 payments
  5. Signet $300 3 payments
  6. Paragonix LUNGguard SherpaCool $299 1 payment
  7. Paragonix LUNGguard Shipper $299 1 payment
  8. BIG60 Inflation device $190 1 payment
  9. AEROmini Stent and Delivery System $190 1 payment
  10. ALIMAXX-ES Stent and Delivery System $190 1 payment
  11. Other $932 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. TransMedics, Inc. $1,116 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

33

Median for Thoracic Surgery: 42

Drug cost

$234

Median for Thoracic Surgery: $318

Branded share of claims

54.5%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $139
Oxycodone Hcl Generic 15 $95

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$63,611

Medicare's payments for the services billed

Medicare patients

96

Average age 72

Services billed

249

31 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
COPD 66%
Arthritis 43%
Ischemic heart disease 42%
Atrial fibrillation 42%
Cancer 42%
Chronic kidney disease 32%
Diabetes 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record